![Jim Pepin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jim Pepin
General Counsel at LEGEND BIOTECH CORPORATION
Profile
Jim Pepin currently works at Legend Biotech Corp., as General Counsel from 2023.
Mr. Pepin also formerly worked at Aimmune Therapeutics, Inc., as Secretary, Senior Vice President & General Counsel from 2020 to 2023 and Nestlé Health Science (Deutschland) GmbH, as Vice President & General Counsel from 2015 to 2020.
Mr. Pepin received his undergraduate degree in 1997 from the University of Virginia and graduate degree in 2001 from the University of Virginia School of Law.
Latest news about Jim Pepin
Jim Pepin active positions
| Companies | Position | Start |
|---|---|---|
| LEGEND BIOTECH CORPORATION | General Counsel | 31/10/2023 |
Former positions of Jim Pepin
| Companies | Position | End |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | General Counsel | 31/10/2023 |
Nestlé Health Science (Deutschland) GmbH
 Nestlé Health Science (Deutschland) GmbH Pharmaceuticals: OtherHealth Technology Nestlé Health Science (Deutschland) GmbH is a company based in Frankfurt, Germany. Part of Nestlé SA, the German company develops nutritional therapies. The company was founded in 2011 and the CEO is Arne Ingo Jurk. | General Counsel | 30/09/2020 |
Training of Jim Pepin
University of Virginia | Undergraduate Degree |
University of Virginia School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LEGEND BIOTECH CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
Nestlé Health Science (Deutschland) GmbH
Nestlé Health Science (Deutschland) GmbH Pharmaceuticals: OtherHealth Technology Nestlé Health Science (Deutschland) GmbH is a company based in Frankfurt, Germany. Part of Nestlé SA, the German company develops nutritional therapies. The company was founded in 2011 and the CEO is Arne Ingo Jurk. | Health Technology |
- Stock Market
- Insiders
- Jim Pepin
